Kezar Life Sciences (KZR) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

KZR Kezar Life Sciences

Watchlist

5.900
+0.010+0.17%

Trading Feb 18 12:55 ET

43.05MMarket Cap-0.45P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Kezar Life Sciences, Inc. Files for Mixed Shelf of Upto $400 Mln
ReutersFeb 5 17:21 ET
Wells Fargo Maintains Kezar Life Sciences(KZR.US) With Hold Rating, Cuts Target Price to $9
Moomoo NewsDec 20, 2024 13:31 ET · Ratings
Express News | Kezar Life Sciences Inc - Enters Into Amendment No. 1 to Rights Agreement
ReutersDec 3, 2024 16:46 ET
H.C. Wainwright Maintains Kezar Life Sciences(KZR.US) With Hold Rating
Moomoo NewsDec 2, 2024 06:31 ET · Ratings
HC Wainwright & Co. Reiterates Neutral on Kezar Life Sciencesto Neutral
BenzingaDec 2, 2024 06:20 ET
KEZAR MARKETS ANNOUNCES RETIREMENT OF CEO WHIT CONARY & NAMES STEVE MIELE AS THE NEW CHIEF EXECUTIVE OFFICER
PR NewswireNov 25, 2024 07:50 ET

Comments

Jaguar8

Oct 29, 2024 22:34

RS tomorrow 1:10. Post RS float 4.5M shares

$Kezar Life Sciences (KZR.US)$

Trytosaveabit

Oct 8, 2024 15:23

Form 13

$Kezar Life Sciences (KZR.US)$ Kezar Life Sciences | SC 13D: Statement of acquisition of beneficial ownership by individuals-TANG CAPITAL MANAGEMENT, LLC(9.9%),KEVIN TANG(9.9%), etc.
SEC· just

Jaguar8

Sep 30, 2024 08:55

NEWS

$Kezar Life Sciences (KZR.US)$
Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients